Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Clinical trials have demonstrated that tirzepatide produces substantial reductions in hemoglobin A1c levels (up to 2.5% in some studies) and significant weight loss (approximately 15-21% of body weight in obesity trials at the highest doses, with somewhat lower percentages in type 2 diabetes trials)
Limited data exist regarding tirzepatide use during breastfeeding
Our medical team provides guidance on minimizing discomfort and ensures your safety with regular follow-up appointments
Yes, tirzepatide may increase testosterone in men with obesity-related hypogonadism by: supporting weight loss improving insulin resistance lowering inflammation reducing estrogen conversion from body fat However, tirzepatide does not replace testosterone therapy for men with primary hypogonadism or significantly suppressed baseline testosterone levels
.jpg)